2,214
Views
7
CrossRef citations to date
0
Altmetric
Epidemiology

History of vigorous leisure-time physical activity and early onset amyotrophic lateral sclerosis (ALS), data from the national ALS registry: 2010–2018

, , , , &
Pages 535-544 | Received 12 Jan 2021, Accepted 23 Mar 2021, Published online: 24 Apr 2021

References

  • Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–55.
  • Mehta P, Kaye W, Raymond J, Punjani R, Larson T, Cohen J, et al. Prevalence of amyotrophic lateral sclerosis - United States, 2015. MMWR Morb Mortal Wkly Rep. 2018;67:1285–9.
  • Deux CJA. Deux cas d'atrophie musculaire progressive avec lesions de la susstance grise et des faisceaux antero-lateraux de la moelle epiniere. Arch Physiol Neurol Pathol. 1869;2: 744.
  • Wagner L, Rechtman L, Jordan H, Ritsick M, Sanchez M, Sorenson E, et al. State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17:128–34.
  • Harwood CA, McDermott CJ, Shaw PJ. Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence. Amyotroph Lateral Scler. 2009;10:191–204.
  • Longstreth WT, Nelson LM, Koepsell TD, van Belle G. Hypotheses to explain the association between vigorous physical activity and amyotrophic lateral sclerosis. Med Hypotheses. 1991;34:144–8.
  • Vanacore N, Cocco P, Fadda D, Dosemeci M. Job strain, hypoxia and risk of amyotrophic lateral sclerosis: results from a death certificate study. Amyotroph Lateral Scler. 2010;11:430–4.
  • Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs RI. Physical activity, trauma, and ALS: a case-control study. Acta Neurol Scand. 1996;94:45–50.
  • Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and varsity athletics in ALS. Neurology. 2002;59:773–5.
  • Beghi E, Logroscino G, Chiò A, Hardiman O, Millul A, Mitchell D, et al. Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study. Amyotroph Lateral Scler. 2010;11:289–92.
  • Lehman EJ, Hein MJ, Baron SL, Gersic CM. Neurodegenerative causes of death among retired National Football League players. Neurology. 2012;79:1970–4.
  • Chio A. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128:472–6.
  • Weisskopf MG, O'Reilly EJ, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, et al. Prospective study of military service and mortality from ALS. Neurology. 2005;64:32–7.
  • Chio A, et al. ALS in Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph Lateral Scler. 2009;10:205–9.
  • Huisman MHB, de Jong SW, Verwijs MC, Schelhaas HJ, van der Kooi AJ, de Visser M, et al. Family history of neurodegenerative and vascular diseases in ALS: a population-based study. Neurology. 2011;77:1363–9.
  • Lacorte E, Ferrigno L, Leoncini E, Corbo M, Boccia S, Vanacore N, et al. Physical activity, and physical activity related to sports, leisure and occupational activity as risk factors for ALS: a systematic review. Neurosci Biobehav Rev. 2016;66:61–79.
  • Veldink JH, Kalmijn S, Groeneveld GJ, Titulaer MJ, Wokke JHJ, van den Berg LH, et al. Physical activity and the association with sporadic ALS. Neurology. 2005;64:241–5.
  • Huisman MHB, Seelen M, de Jong SW, Dorresteijn KRIS, van Doormaal PTC, van der Kooi AJ, et al. Lifetime physical activity and the risk of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;84:976–81.
  • Chio A, Calvo A, Mazzini L, Cantello R, Mora G, Moglia C, et al., On behalf of PARALS. Extensive genetics of ALS: a population-based study in Italy. Neurology 2012;79:1983–9.
  • Al-Chalabi A, Hardiman O, Kiernan MC, Chiò A, Rix-Brooks B, van den Berg LH, et al. Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol. 2016;15:1182–94.
  • Service UPH. ALS registry act. 110th congress. Public law. US Public Health Service: Washington, DC; 2008. p. 110–373.
  • Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci. 1994;124:96–107.
  • Antao VC, Horton DK. The National Amyotrophic Lateral Sclerosis (ALS) Registry. J Environ Health. 2012;75:28–30.
  • Allen KD, Kasarskis EJ, Bedlack RS, Rozear MP, Morgenlander JC, Sabet A, et al. The National Registry of Veterans with amyotrophic lateral sclerosis. Neuroepidemiology 2008;30:180–90.
  • Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
  • Horton DK, Mehta P, Antao VC. Quantifying a nonnotifiable disease in the United States: the National Amyotrophic Lateral Sclerosis Registry model. JAMA 2014;312:1097–8.
  • Services UDoHaH. US department of health and human services regions. U.D.o.H.a.H. Services: Washington, DC; 2017.
  • Bryan L, Kaye W, Antao V, Mehta P, Muravov O, Horton DK, et al. Preliminary results of National Amyotrophic Lateral Sclerosis (ALS) Registry risk factor survey data. PLoS One. 2016;11:e0153683.
  • Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10:37–48.
  • Armstrong T, Bull F. Development of the World Health Organization Global Physical Activity Questionnaire (GPAQ). J Public Health. 2006;14:66–70.
  • Rudolf K, Lammer F, Stassen G, Froböse I, Schaller A. Show cards of the Global Physical Activity Questionnaire (GPAQ) - do they impact validity? A crossover study. BMC Public Health. 2020;20:223.
  • Chasan-Taber L, Erickson JB, McBride JW, Nasca PC, Chasan-Taber S, Freedson PS, et al. Reproducibility of a self-administered lifetime physical activity questionnaire among female college alumnae. Am J Epidemiol. 2002;155:282–9.
  • Khishchenko N, Allen KD, Coffman CJ, Kasarskis EJ, Lindquist JH, Morgenlander JC, et al. Time to diagnosis in the National Registry of Veterans with Amyotrophic Lateral Sclerosis. Amyotroph Lateral Scler. 2010;11:125–32.
  • Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1–452.
  • Cooper KH. The History of Aerobics (50 Years and Still Counting). Res Q Exerc Sport. 2018;89:129–34.
  • SAS Institute. SAS 9.4. Cary, NC: SAS Institute.
  • Eisen A. Amyotrophic lateral sclerosis is a multifactorial disease. Muscle Nerve. 1995;18:741–52.
  • Warburton DER, Bredin SSD. Health benefits of physical activity: a systematic review of current systematic reviews. Curr Opin Cardiol. 2017;32:541–56.
  • Amanat S, Ghahri S, Dianatinasab A, Fararouei M, Dianatinasab M. Exercise and type 2 diabetes. Adv Exp Med Biol. 2020;1228:91–105.
  • Fuzeki E, Engeroff T, Banzer W. Health benefits of light-intensity physical activity: a systematic review of accelerometer data of the National Health and Nutrition Examination Survey (NHANES). Sports Med. 2017;47:1769–93.
  • Pupillo E, Messina P, Giussani G, Logroscino G, Zoccolella S, Chiò A, et al., EURALS Consortium. Physical activity and amyotrophic lateral sclerosis: a European population-based case-control study. Ann Neurol. 2014;75:708–16.
  • Luna J, Logroscino G, Couratier P, Marin B. Current issues in ALS epidemiology: variation of ALS occurrence between populations and physical activity as a risk factor. Rev Neurol (Paris). 2017;173:244–53.
  • Hamidou B, Marin B, Lautrette G, Nicol M, Camu W, Corcia P, et al. Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:519–27.
  • Kellogg J, Bottman L, Arra EJ, Selkirk SM, Kozlowski F. Nutrition management methods effective in increasing weight, survival time and functional status in ALS patients: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:7–11.
  • August KJ, Sorkin DH. Racial/ethnic disparities in exercise and dietary behaviors of middle-aged and older adults. J Gen Intern Med. 2011;26:245–50.
  • Rhoades JA. Exercise in adults, age 18 and older, in the United States, 2002: estimates for the noninstitutionalized population. Rockville, MD: Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality; 2005.
  • Simioni C, Zauli G, Martelli AM, Vitale M, Sacchetti G, Gonelli A, et al. Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging. Oncotarget 2018;9:17181–98.
  • Kawamura T, Muraoka I. Exercise-induced oxidative stress and the effects of antioxidant intake from a physiological viewpoint. Antioxidants. 2018;7:119.
  • Hu Y, Cao C, Qin XY, Yu Y, Yuan J, Zhao Y, et al. Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Sci Rep. 2017;7:9094.
  • Lyon MS, Wosiski-Kuhn M, Gillespie R, Caress J, Milligan C. Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology. Muscle Nerve. 2019;59:10–22.
  • Kats D, Evenson KR, Zeng D, Avery CL, Palta P, Kritchevsky SB, et al. Leisure-time physical activity volume, intensity, and duration from mid- to late-life in U.S. subpopulations by race and sex. The Atherosclerosis Risk In Communities (ARIC) Study. Aging. 2020;12:4592–602.
  • Murray TC, Rodgers WM, Fraser SN. Exploring the relationship between socioeconomic status, control beliefs and exercise behavior: a multiple mediator model. J Behav Med. 2012;35:63–73.
  • Bureau UC. Total population 2014 American community survey 1-year. Washington DC: US Census Bureau, U.D.o. Commerce; 2014.
  • Watanabe H, Atsuta N, Nakamura R, Hirakawa A, Watanabe H, Ito M, et al. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:230–6.
  • Kaye WE, Wagner L, Wu R, Mehta P. Evaluating the completeness of the national ALS registry, United States. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:112–7.